These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Value of endocrine therapy for early and locally advanced prostate cancer. Wirth MP; Froehner M Drugs Aging; 2003; 20(2):115-24. PubMed ID: 12534312 [TBL] [Abstract][Full Text] [Related]
13. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer. Pisansky TM Urology; 2003 Dec; 62 Suppl 1():36-45. PubMed ID: 14747040 [TBL] [Abstract][Full Text] [Related]
14. [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer]. Akaza H; Hirao Y; Labrie F; Soloway MS Hinyokika Kiyo; 2003 Dec; 49(12):771-7. PubMed ID: 14978964 [TBL] [Abstract][Full Text] [Related]
15. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. Wieder JA; Soloway MS J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867 [TBL] [Abstract][Full Text] [Related]
16. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378 [TBL] [Abstract][Full Text] [Related]
17. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Eulau SM; Tate DJ; Stamey TA; Bagshaw MA; Hancock SL Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):735-40. PubMed ID: 9652832 [TBL] [Abstract][Full Text] [Related]
18. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy. Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128 [TBL] [Abstract][Full Text] [Related]
19. Management strategies for locally advanced prostate cancer. Jani AB Drugs Aging; 2006; 23(2):119-29. PubMed ID: 16536635 [TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of hormonal therapy for carcinoma of the prostate. Chodak GW; Keane T; Klotz L; Urology; 2002 Aug; 60(2):201-8. PubMed ID: 12137810 [No Abstract] [Full Text] [Related] [Next] [New Search]